| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $493.3M | +2.0% | +9.2% |
| Cost of Revenue | $85.4M | -2.4% | -3.3% |
| Gross Profit | $407.9M | +3.0% | +12.2% |
| R&D Expense | $74.1M | -0.9% | +17.5% |
| SG&A Expense | $295.3M | +4.1% | +14.1% |
| Operating Income | $112.6M | +0.3% | +7.4% |
| Interest Expense | $1.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $375.0M | -29.5% | +15.1% |
| Accounts Receivable | $50.4M | +26.3% | +144.9% |
| Inventory | $1.8M | +12.5% | +35.2% |
| Current Assets | $2.54B | +5.8% | +28.5% |
| Total Assets | $4.25B | +5.3% | +21.6% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $482.8M | — | — |
| Capital Expenditures | $197.4M | — | — |
| Investing Cash Flow | -$659.2M | — | — |
| Financing Cash Flow | -$2.17B | — | — |
| Free Cash Flow | $285.4M | — | — |
| +37.5% |
| +39.4% |
| Pre-tax Income | $152.8M | +30.4% | +41.1% |
| Income Tax | $42.1M | +52.0% | +20.2% |
| Net Income | $110.7M | +23.7% | +51.1% |
| EPS (Basic) | $1.97 | +23.9% | +50.4% |
| EPS (Diluted) | $1.96 | +24.1% | +49.6% |
| $2.08B |
| +12.4% |
| +25.2% |
| Total Liabilities | $2.54B | +13.7% | +25.0% |
| Stockholders' Equity | $1.71B | -5.1% | +16.7% |